Arcturus Therapeutics Holdings Inc. (ARCT)

NGM – Real Time Price. Currency in USD

8.25

-0.39 (-4.46%)

At close: May 12, 2026, 4:00 PM EDT

8.31

+0.06 (0.73%)

Pre-market: May 13, 2026, 6:11 AM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

67M

138M

158M

206M

Cost of goods sold

-3M

-4M

-3M

Gross Profit

64M

135M

155M

Operating expenses (excl. COGS)

-139M

-174M

-159M

-187M

Operating Income

-75M

-39M

-4M

17M

Non-operating income, total

-42M

-24M

-6M

Pretax income

-66M

-81M

-28M

11M

Equity in earnings

-515K

Taxes

-2M

-1M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-66M

-81M

-30M

Arcturus Therapeutics Holdings Inc. (ARCT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Arcturus Therapeutics Holdings Inc. (ARCT)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Arcturus Therapeutics Holdings Inc. (ARCT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Arcturus Therapeutics Holdings Inc. (ARCT)

Income Statement (Annual)

Income Statement (Annual)